Newborn hearing screening with transient evoked otoacoustic emission: a prospective study in a tertiary health care centre

Shashidhar S. Suligavi, Prakhar Upadhyay, Prasen Reddy, S. S. Doddamani, M. N. Patil


Background: As hearing impairment is a hidden disability, it is usually detected after 2-3 years by which time there will be irreversible stunting of the skills and hence rehabilitation procedures like hearing aids, speech therapy are unable to ensure complete development of speech. Therefore hearing impairment should be diagnosed as early as           6 months to ensure timely therapy. The objective of the study is to identify the proportion of incidence of hearing impairment in neonates using transient evoked otoacoustic emissions (TEOAE) as a screening tool.

Methods: Prospective study on 800 newborns in a tertiary hospital using TEOAE. Brain stem evoked response audiometry (BERA) was used to confirm hearing loss in neonates who failed TEOAE.  

Results: Thirteen out of 800 newborns failed TEOAE test on first screening. Two failed on 2nd TEOAE test done after 3-4 weeks. Hearing loss was later confirmed in them with BERA test.

Conclusions: Proportion of hearing loss in our study was 0.25%. Hearing screening should be done as early as possible so that deaf children are rehabilitated early.


Transient evoked otoacoustic emissions, Newborns hearing screening, Brain stem evoked response audiometry

Full Text:



Bachmann KR, Arvedson JV. Early identification and intervention for children who are hearing impaired. Paediatr Rev. 1998:19;155-63.

Nagapoornima P, Ramesh A, Srilakshmi, Rao S, Patricia PL, Gore M, Dominic M, Swarnarekha. Universal hearing screening. Indian J Paedia. 2007;74:172-85.

Yoshinaga, Itano S, Sedey AL, Coulter DK, Mehl AL. Language of early and later identified children with hearing loss. Paediatrics. 1998;102(5):1161-71.

Robert MK, Bonita MD, Stanton, Joseph G, Nina FS. Nelson Textbook of Paediatrics. 18th edition: Elsevier; 2015:2188-2196.

Keren R, Helfand M, Homer C, McPhilips H, Lieu TA. Projected Cost effectiveness of state wide universal newborn hearing screening. Pediatrics. 2002;110(5)855-64.

Marteletto J, Costa D, Furtadode V, Almeida, Piresdeoliveira CAC, Sampaio ALL. Transient and distortion product evoked oto acoustic emissions in premature infants. Intl Arch Otorhinolaryngol. Saa Paulo. 2000;13:309-16.

Grapo de apoio a triagen auditiva neonatal universal (GATANU). Available at Disponival Accessed on 18 January 2016.

Hadad J. Hearing Loss In: R.E. Behrman, R. Kliegman and H.B. Jenson. Nelson Text book of Paediatrics.17th edition, Philadelphia: Saunders; 2004:2129-2134.

White KR, Vohr BR, Behrens TR. Universal newborn hearing screening using transient evoked otoacoustic emissions : results of the rhode island hearing assessment project. Seminars in Hearing. 1992;14:18-29.

Jewel J, Varghese PV, Singh T, Varghese A. newborn hearing screening experience at a tertiary hospital in NorthWest India. Int J Otolaryngology Head Neck Surg. 2013;2:211-4.

Stevens JC, Webb HD, Hutchinson J, Buffin JT, Smith MF. Otoacoustic emission. Int J Pedia Otorhinolaryngology. 1995;32:213-6.

Norton SJ, Gorga MA, Widen JE, Folsom RC, Singer Y, Cone WB et al. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emissions, distortion product otoacoustic emissions and auditory brainstem response test performances. Ear and Hearing. 2000;21:508-28.

Jewel J, Varghese PV, Singh T, Varghese A. newborn hearing screening experience at a tertiary hospital in northwest India. Int J Otolaryngology Head Neck Surg. 2013;2:211-4.